From a primary lesion on the upper back, which organ is most likely to develop metastases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metastatic Pattern from Upper Back Lesions

A malignant wound or lesion on the upper back most commonly metastasizes to the lungs, followed by regional lymph nodes, with the specific pattern depending on the histologic type of the primary tumor.

Primary Consideration: Soft Tissue Sarcoma

Given the anatomic location (upper back/trunk), the most likely malignant "wound" would be a soft tissue sarcoma or melanoma. The metastatic patterns differ significantly between these entities:

Soft Tissue Sarcomas of the Trunk

The lungs are the predominant site of hematogenous metastasis from trunk soft tissue sarcomas, making chest imaging essential for staging and surveillance. 1

  • High-grade sarcomas demonstrate a strong propensity for hematogenous spread to the lungs, which is why imaging of the chest is considered essential for accurate staging 1
  • The NCCN guidelines specifically emphasize that given the risk for hematogenous spread from high-grade sarcoma to the lungs, chest imaging is mandatory 1
  • Certain histologic subtypes have additional metastatic patterns: myxoid round cell liposarcoma can metastasize to the spine, leiomyosarcoma and epithelioid sarcoma may spread to abdominal/pelvic sites, and angiosarcomas can involve the brain 1
  • The propensities to spread vary among sarcoma subtypes, requiring individualized imaging protocols based on histology 1

Melanoma from Upper Back

For melanoma arising on the upper back, lymph nodes represent the initial and most common site of metastatic spread, with the lungs, liver, and brain being the most frequent distant metastatic sites. 2

  • Regional nodal involvement occurs in 5-40% of patients depending on primary tumor thickness and level of invasion 2
  • Lymph nodes are the initial metastatic site, with risk directly correlated to primary tumor characteristics 2
  • Among distant sites, the lungs are among the most frequently involved organs 2
  • The liver and brain are also commonly affected, with these sites associated with particularly poor prognosis 2
  • Abdominal, thoracic, and cerebral CT scans are the most useful imaging modalities for detecting distant metastases in melanoma 2

Clinical Implications for Surveillance

Surveillance protocols should focus primarily on chest imaging regardless of whether the lesion is sarcoma or melanoma, as pulmonary metastases are the most common distant site and often asymptomatic when surgically resectable. 1, 2

  • Most recurrences occur within 3 years after treatment, with median time to relapse of 1-2 years 1
  • High-risk patients should undergo chest imaging every 3-4 months in the first 2-3 years, then twice yearly up to 5 years 1
  • Early detection of lung metastases may have prognostic implications, as they are often asymptomatic at a stage suitable for surgical resection 1

Important Caveats

The absence of typical lymph node metastases in expected drainage patterns should raise suspicion for alternative primary sites or unusual metastatic patterns. 1

  • Tumors that metastasize along preformed lymphatic pathways are typically surrounded by lymphatic metastases in characteristic locations 1
  • The closest adjacent lymph node groups are usually most heavily involved in lymphatic spread 1
  • Widespread disease without lymph node involvement in typical sites may refute the presence of a primary tumor in a suspected location 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metastatic Patterns and Prognosis in Melanoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.